Related references
Note: Only part of the references are listed.Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Retapamulin - A review of its use in the management of impetigo and other uncomplicated superficial skin infections
Lily P. H. Yang et al.
DRUGS (2008)
An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit
Sinead Kelly et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06
Russell Hope et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community
Dilip Nathwani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model
O. Kandemir et al.
JOURNAL OF CHEMOTHERAPY (2008)
Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2008)
Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series
Nalini Rao et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom
Verena Schneider-Lindner et al.
EMERGING INFECTIOUS DISEASES (2007)
Response to emerging infection leading to outbreak of linezolid-resistant enterococci
Marion A. Kainer et al.
EMERGING INFECTIOUS DISEASES (2007)
Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus
Mary Jo Cenizal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia
Meghan N. Jeffres et al.
CLINICAL THERAPEUTICS (2007)
Linezolid for the treatment of patients with central nervous system infection
Fotinie Ntziora et al.
ANNALS OF PHARMACOTHERAPY (2007)
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus
Dennis L. Stevens et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid
Seok-Ming Toh et al.
MOLECULAR MICROBIOLOGY (2007)
Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Staphylococcus aureus bacteremia in older adults:: Predictors of 7-day mortality and infection with a methicillin-resistant strain
Mazen S. Bader
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia -: Specific evaluation of vancomycin pharmacokinetic indices
Meghan N. Jeffres et al.
CHEST (2006)
High-level mupirocin resistance within methicillin-resistant Staphylococcus aureus pandemic lineages
Eduardo Perez-Roth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Tigecycline: A critical analysis
Gary E. Stein et al.
CLINICAL INFECTIOUS DISEASES (2006)
Mortality after Staphylococcus aureus bacteraemia in two acute hospitals in Oxfordshire, 1997-2003:: cohort study
David H. Wyllie et al.
BRITISH MEDICAL JOURNAL (2006)
Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: A retrospective study
Eric Senneville et al.
CLINICAL THERAPEUTICS (2006)
Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 μg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis
Darego O. Maclayton et al.
CLINICAL THERAPEUTICS (2006)
Comment on Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
Leonard Leibovici et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis
P Gerber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
CG Gemmell et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage
MG Bonora et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis
MS Rouse et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center
Thomas E. Dobbs et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Mupirocin for controlling methicillin-resistant Staphylococcus aureus:: Lessons from a decade of use at a University Hospital
AM Vivoni et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact
JA Silverman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model
LY Yin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
J Weigelt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals
C Nonhoff et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Linezolid in the treatment of Gram-positive prosthetic joint infections
M Bassetti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus Bacteremia
VG Fowler et al.
CLINICAL INFECTIOUS DISEASES (2005)
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia
SD Reed et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections
FME Wagenlehner et al.
CHEMOTHERAPY (2005)
Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania
NC Clark et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Is methicillin-resistant Staphylococcus aureus more contagious than methicillin-susceptible S. aureus in a surgical intensive care unit?
PJ Drinka et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals
GL Cartolano et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission:: distinguishing between community-acquired versus healthcare-associated strains
E Tacconelli et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit
MA de la Cal et al.
JOURNAL OF HOSPITAL INFECTION (2004)
Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia
SH Kim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber
EW Hall et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Practice guidelines for outpatient parenteral antimicrobial therapy
AD Tice et al.
CLINICAL INFECTIOUS DISEASES (2004)
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
PA Moise-Broder et al.
CLINICAL INFECTIOUS DISEASES (2004)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial
L Silvestri et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients
RG Postier et al.
CLINICAL THERAPEUTICS (2004)
Staphylococcus aureus bacteremia: Compliance with standard treatment, long-term outcome and predictors of relapse
LB Johnson et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Community-acquired methicillin-resistant Staphylococcus aureus:: An emerging pathogen
B Saïd-Salim et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia
TP Lodise et al.
CLINICAL INFECTIOUS DISEASES (2003)
Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission
JA Jernigan et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA
DP Calfee et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of staphylococcus aureus and enterococcus
CA Muto et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital
AA Muller et al.
CLINICAL INFECTIOUS DISEASES (2003)
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
S Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection
JJ Engemann et al.
CLINICAL INFECTIOUS DISEASES (2003)
Community-acquired methicillin-resistant Staphylococcus aureus:: A meta-analysis of prevalence and risk factors
CD Salgado et al.
CLINICAL INFECTIOUS DISEASES (2003)
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis
SE Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2003)
Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S-aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia
M Melzer et al.
CLINICAL INFECTIOUS DISEASES (2003)
Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs
A Geissler et al.
INTENSIVE CARE MEDICINE (2003)
Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients
L Silvestri et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2002)
Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus
SI Blot et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin
B Maraha et al.
CLINICAL MICROBIOLOGY AND INFECTION (2002)
Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci
A Sander et al.
INTENSIVE CARE MEDICINE (2002)
A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics
HM Aucken et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Methicillin-resistant Staphylococcus aureus incidence and outcome in patients with neck of femur fractures
OA Khan et al.
JOURNAL OF HOSPITAL INFECTION (2002)
Genome and virulence determinants of high virulence community-acquired MRSA
T Baba et al.
LANCET (2002)
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli
S Harbarth et al.
CLINICAL INFECTIOUS DISEASES (2001)
Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study
M Wysocki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections
K Gupta et al.
ANNALS OF INTERNAL MEDICINE (2001)
Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus
S Harbarth et al.
CLINICAL INFECTIOUS DISEASES (2000)
Methicillin-resistant Staphylococcus aureus in a teaching hospital:: investigation of nosocomial transmission using a matched case-control study
G Dziekan et al.
JOURNAL OF HOSPITAL INFECTION (2000)
Staphylococcus aureus bacteremia:: Predictors of 30-day mortality in a large cohort
JM Mylotte et al.
CLINICAL INFECTIOUS DISEASES (2000)
National guidelines for the judicious use of glycopeptides in Belgium
B Gordts et al.
CLINICAL MICROBIOLOGY AND INFECTION (2000)
Rotation and restricted use of antibiotics in a medical intensive cave unit - Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria
D Gruson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
